Hoth Therapeutics Shares up 83% on Positive Mid-Stage Trial Data for Skin Toxicity Treatment
Hoth Therapeutics 股票因皮肤毒性治疗的中期试验数据积极而上涨83%
Hoth Therapeutics Shares up 83% on Positive Mid-Stage Trial Data for Skin Toxicity Treatment
Hoth Therapeutics 股票因皮肤毒性治疗的中期试验数据积极而上涨83%
使用浏览器的分享功能,分享给你的好友吧